Mediolanum International Funds’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5M Sell
61,723
-137,568
-69% -$11.1M 0.04% 286
2026
Q1
$17.1M Sell
199,291
-231,191
-54% -$22.1M 0.18% 142
2025
Q4
$41.6M Buy
430,482
+185,125
+75% +$18M 0.42% 46
2025
Q3
$23.1M Buy
245,357
+60,172
+32% +$5.53M 0.24% 97
2025
Q2
$15.9M Sell
185,185
-52,160
-22% -$4.42M 0.19% 132
2025
Q1
$20.8M Sell
237,345
-4,774
-2% -$427K 0.29% 82
2024
Q4
$19.2M Sell
242,119
-50,396
-17% -$4.36M 0.25% 86
2024
Q3
$26.1M Sell
292,515
-9,714
-3% -$817K 0.36% 63
2024
Q2
$22.4M Sell
302,229
-2,000
-0.7% -$164K 0.37% 64
2024
Q1
$26.4M Buy
+304,229
New +$26M 0.43% 55

Other funds holding MDT

Mediolanum International Funds's MDT Position: Q2 2026 in Review

Mediolanum International Funds reduced its Medtronic (MDT) stake by 69% in Q2 2026, selling an estimated $11.1M and leaving 61,723 shares worth $5M. The position accounts for 0.04% of the portfolio, ranked #286.

Mediolanum International Funds first reported a position in MDT in Q1 2024 and has held it in 10 quarters since. The position peaked at $41.6M in Q4 2025. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Mediolanum International Funds held 61,723 shares of Medtronic worth $5M as of Q2 2026.
  • Mediolanum International Funds sold 137,568 Medtronic shares in Q2 2026, an estimated $11.1M.
  • Medtronic made up 0.04% of Mediolanum International Funds's portfolio in Q2 2026, its #286 holding.
  • Mediolanum International Funds first reported a position in Medtronic in Q1 2024 and has held it in 10 quarters since.
  • Mediolanum International Funds's Medtronic position peaked at $41.6M in Q4 2025.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Mediolanum International Funds's 13F filing for Q2 2026, filed 23 Jul 2026.